Here’s the most unappreciated AI beneficiary right now, according to Ark Invest’s Cathie Wood - MarketWatch
1. Cathie Wood predicts U.S. technology will thrive under Trump's administration. 2. AI will significantly reduce drug discovery times to eight years. 3. Crispr Therapeutics (CRSP) is viewed positively for innovation in healthcare. 4. Healthcare spending is shifting from treatment to cure-focused therapies. 5. Upcoming innovations in robotics and AI will drive future market changes.